AArkstore enterprise 16th December 2014
Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Browse Full Report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60339/respiratory-syncytial-virusrsv-prophylactic-pipeline-assessment-and-market-forecasts Published: Jan 2012 | No. Of Pages: 60 Pages PDF: $ 3995 | Site Licence : $ 7990 | Enterprise Wide Licence : $ 11985
Summary The industry analysis specialist, has released its new report, “Respiratory Syncytial Virus (RSV) Prophylactic Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Respiratory Syncytial Virus (RSV) Prophylactic market. The report identifies the key trends shaping and driving the global Respiratory Syncytial Virus (RSV) Prophylactic market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Respiratory Syncytial Virus (RSV) Prophylactic sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope The report provides information on the key drivers and challenges of the Respiratory Syncytial Virus (RSV) Prophylactic market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Respiratory Syncytial Virus (RSV) Prophylactic market revenues data from 2006 to 2011, forecast for eight years to 2019.
Website : http://www.aarkstore.com/
AArkstore enterprise - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Respiratory Syncytial Virus (RSV) Prophylactic market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Respiratory Syncytial Virus (RSV) Prophylactic market. - Analysis of key recent licensing and partnership agreements in Respiratory Syncytial Virus (RSV) Prophylactic market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Respiratory Syncytial Virus (RSV) Prophylactic market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Respiratory Syncytial Virus (RSV) Prophylactic market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Respiratory Syncytial Virus (RSV) Prophylactic market landscape? – Identify, understand and capitalize.
Website : http://www.aarkstore.com/
AArkstore enterprise
Special Discount on Global Data Market Research Reports: Click here an avail Discount offer on Global Data market research reports: http://www.aarkstore.com/discount.php Discount Valid till 31st December 2014 For Research Reports Call us on: +91 9987295242 OR Mail us at contact@aarkstore.com
Tables Of Contents 2 Respiratory Syncytial Virus Prophylactic - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology 2.4 Symptoms 2.5 Diagnosis 2.6 Pathophysiology 2.7 Prevention and Management Pattern 2.8 GlobalData Pipeline Report Guidance 3 Respiratory Syncytial Virus Prophylactic - Market Characterization 3.1 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - Global 3.2 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - Global 3.3 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - the US
Website : http://www.aarkstore.com/
AArkstore enterprise 3.4 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - the US 3.5 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - France 3.6 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - France 3.7 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - Germany 3.8 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - Germany 3.9 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - Italy 3.10 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - Italy 3.11 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - Spain 3.12 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - Spain 3.13 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - The UK 3.14 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - The UK 3.15 Respiratory Syncytial Virus Prophylactic Market Size (2006-2011) - Japan 3.16 Respiratory Syncytial Virus Prophylactic Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Respiratory Syncytial Virus Prophylactic Market 3.17.1 Drivers for the Respiratory Syncytial Virus Prophylactic Market 3.17.2 Barriers for the Respiratory Syncytial Virus Prophylactic Market 3.18 Opportunity and Unmet Need 3.19 Key Takeaway 4 Respiratory Syncytial Virus Prophylactic - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile for the Major Market Product in the Respiratory Syncytial Virus Prophylactic Market 4.3.1 Synagis (palivizumab)
Website : http://www.aarkstore.com/
AArkstore enterprise 4.4 Key Takeaway 5 Respiratory Syncytial Virus Prophylactic - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Respiratory Syncytial Virus Prophylactic - Pipeline Assessment by Phase of Development 5.3.1 Respiratory Syncytial Virus Prophylactic - Phase II Pipeline 5.3.2 Respiratory Syncytial Virus Prophylactic - Phase I Pipeline 5.3.3 Respiratory Syncytial Virus Prophylactic - Discovery and Preclinical Pipeline 5.4 Respiratory Syncytial Virus Prophylactic - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Key Takeaway 6 Respiratory Syncytial Virus Prophylactic - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (the US, EU5 & Japan) 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Clinical Trials by Sponsors 6.5 Brief Profiles of Top 10 Companies Participating in Clinical Trials 7 Respiratory Syncytial Virus Prophylactic - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Respiratory Syncytial Virus Prophylactic - Future Players 8.1 Introduction 8.2 Company Profiles
Website : http://www.aarkstore.com/
AArkstore enterprise 8.2.1 AstraZeneca PLC 8.2.2 Sealife PHARMA GMBH 8.2.3 Other Companies in the Respiratory Syncytial Virus Prophylactic Pipeline 8.2.4 Key Takeaway 9 Respiratory Syncytial Virus Prophylactic - Licensing & Partnership Deals, 2011 10 Respiratory Syncytial Virus Prophylactic - Appendix 10.1 Market Definitions 10.2 Acronyms 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: Maximum Number of Monthly Doses of Synagis for Respiratory Syncytial Virus Prophylaxis Table 2: Respiratory Syncytial Virus Prophylactic Market, Global, Revenue ($m), 2006-2011 Table 3: Respiratory Syncytial Virus Prophylactic Market, Global, Forecast ($m), 2011-2019 Table 4: Respiratory Syncytial Virus Prophylactic Market, the US, Revenue ($m), 2006-2011
Website : http://www.aarkstore.com/
AArkstore enterprise Table 5: Respiratory Syncytial Virus Prophylactic Market, the US, Forecast ($m), 2011-2019 Table 6: Respiratory Syncytial Virus Prophylactic Market, France, Revenue ($m), 2006-2011 Table 7: Respiratory Syncytial Virus Prophylactic Market, France, Forecast ($m), 2011-2019 Table 8: Respiratory Syncytial Virus Prophylactic Market, Germany, Revenue ($m), 2006-2011 Table 9: Respiratory Syncytial Virus Prophylactic Market, Germany, Forecast ($m), 2011-2019 Table 10: Respiratory Syncytial Virus Prophylactic Market, Italy, Revenue ($m), 2006-2011 Table 11: Respiratory Syncytial Virus Prophylactic Market, Italy, Forecast ($m), 2011-2019 Table 12: Respiratory Syncytial Virus Prophylactic Market, Spain, Revenue ($m), 2006-2011 Table 13: Respiratory Syncytial Virus Prophylactic Market, Spain, Forecast ($m), 2011-2019 Table 14: Respiratory Syncytial Virus Prophylactic Market, The UK, Revenue ($m), 2006-2011 Table 15: Respiratory Syncytial Virus Prophylactic Market, The UK, Forecast ($m), 2011-2019 Table 16: Respiratory Syncytial Virus Prophylactic Market, Japan, Revenue ($m), 2006-2011 Table 17: Respiratory Syncytial Virus Prophylactic Market, Japan, Forecast ($m), 2011-2019 Table 18: Respiratory Syncytial Virus Prophylactic - Phase II Pipeline, 2011 Table 19: Respiratory Syncytial Virus Prophylactic - Phase I Pipeline, 2011 Table 20: Respiratory Syncytial Virus Prophylactic - Discovery and Preclinical Pipeline, 2011 Table 21: Respiratory Syncytial Virus Prophylactic, Global, Clinical Trials, 2011 Table 22: Respiratory Syncytial Virus Prophylactic, Global, Clinical Trials by Phase, 2011 Table 23: Respiratory Syncytial Virus Prophylactic, Global, Clinical Trials by Status of Development, 2011 Table 24: Respiratory Syncytial Virus Prophylactic, Global, Prominent Sponsors, 2011 Table 25: Respiratory Syncytial Virus Prophylactic, Global, Top Ten Companies by Phase, 2011 Table 26: AstraZeneca, Pipeline Products, 2011 Table 27: Sealife PHARMA, Pipeline Products, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Table 28: Respiratory Syncytial Virus Prophylactic - Other Companies in Pipeline Table 29: Respiratory Syncytial Virus Prophylactic, Global, Deals, 2011
List Of Figures Figure 1: Respiratory Syncytial Virus Structure and Pharmacologic Targets Figure 2: Respiratory Syncytial Virus Prophylactic Market, Global, Revenue ($m), 2006-2011 Figure 3: Respiratory Syncytial Virus Prophylactic Market, Global, Forecast ($m), 2011-2019 Figure 4: Respiratory Syncytial Virus Prophylactic Market, the US, Revenue ($m), 2006-2011 Figure 5: Respiratory Syncytial Virus Prophylactic Market, the US, Forecast ($m), 2011-2019 Figure 6: Respiratory Syncytial Virus Prophylactic Market, France, Revenue ($m), 2006-2011 Figure 7: Respiratory Syncytial Virus Prophylactic Market, France, Forecast ($m), 2011-2019 Figure 8: Respiratory Syncytial Virus Prophylactic Market, Germany, Revenue ($m), 2006-2011 Figure 9: Respiratory Syncytial Virus Prophylactic Market, Germany, Forecast ($m), 2011-2019 Figure 10: Respiratory Syncytial Virus Prophylactic Market, Italy, Revenue ($m), 2006-2011 Figure 11: Respiratory Syncytial Virus Prophylactic Market, Italy, Forecast ($m), 2011-2019 Figure 12: Respiratory Syncytial Virus Prophylactic Market, Spain, Revenue ($m), 2006-2011 Figure 13: Respiratory Syncytial Virus Prophylactic Market, Spain, Forecast ($m), 2011-2019 Figure 14: Respiratory Syncytial Virus Prophylactic Market, The UK, Revenue ($m), 2006-2011 Figure 15 Respiratory Syncytial Virus Prophylactic Market, The UK, Forecast ($m), 2011-2019 Figure 16: Respiratory Syncytial Virus Prophylactic Market, Japan, Revenue ($m), 2006-2011 Figure 17: Respiratory Syncytial Virus Prophylactic Market, Japan, Forecast ($m), 2011-2019 Figure 18: Opportunity and Unmet Need in the Respiratory Syncytial Virus Prophylactic Market, 2011 Figure 19: Respiratory Syncytial Virus Prophylactic - Strategic Competitor Assessment, 2011
Website : http://www.aarkstore.com/
AArkstore enterprise Figure 20: Respiratory Syncytial Virus Prophylactic - Clinical Pipeline by Mechanism of Action, 2011 Figure 21: Respiratory Syncytial Virus Prophylactic - Pipeline by Phase of Development, 2011 Figure 22: Respiratory Syncytial Virus Prophylactic - Technology Trends Analytics Framework, 2011 Figure 23: Respiratory Syncytial Virus Prophylactic - Technology Trends Analytics Framework - Description, 2011 Figure 24: Respiratory Syncytial Virus Prophylactic, Global, Clinical Trials by Country, 2011 Figure 25: Respiratory Syncytial Virus Prophylactic, Global, Clinical Trials by Phase (%), 2011 Figure 26: Respiratory Syncytial Virus Prophylactic, Global, Clinical Trials by Status of Development (%), 2011 Figure 27: Respiratory Syncytial Virus Prophylactic, Global, Overall Sponsors (%), 2011 Figure 28: Respiratory Syncytial Virus Prophylactic, Global, Prominent Sponsors (%), 2011 Figure 29: Respiratory Syncytial Virus Prophylactic, Global, Top Ten Companies by Phase, 2011 Figure 30: Respiratory Syncytial Virus Prophylactic Market, Drivers and Barriers, 2011 Figure 31: Implications for Future Market Competition in the Respiratory Syncytial Virus Prophylactic Market, 2011 Figure 32: Respiratory Syncytial Virus Prophylactic Market - Clinical Pipeline by Company, 2011 Figure 33: GlobalData Market Forecasting Model
Related reports: Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Quark Pharmaceuticals, Inc. - Product Pipeline Review - 2014 PLx Pharma Inc. - Product Pipeline Review - 2014 Pharnext SAS - Product Pipeline Review - 2014 Novabiotics Ltd - Product Pipeline Review - 2014 Trellis Bioscience, Inc. - Product Pipeline Review - 2014 Bionor Pharma ASA - Product Pipeline Review - 2014
Website : http://www.aarkstore.com/
AArkstore enterprise AFFiRiS AG - Product Pipeline Review - 2014 Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
About Aarkstore Enterprise Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
You can order full Report with TOC and Sample page visit: http://www.aarkstore.com/pharmaceuticals-healthcare/60339/respiratory-syncytial-virus-rsvprophylactic-pipeline-assessment-and-market-forecasts
Contact Details: Aarkstore Enterprise Phone: +91 998 729 5242 Email: enquiry@aarkstore.com Our Website: http://www.aarkstore.com Facebook: https://www.facebook.com/aarkstoredotcom Linkedin: http://www.linkedin.com/company/aarkstore-enterprise
Website : http://www.aarkstore.com/